Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activity of the hypnotics, flunitrazepam and triazolam, in man.

Literature DB >> 6101959

Activity of the hypnotics, flunitrazepam and triazolam, in man.

A N Nicholson, B M Stone.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1980 PMID： 6101959 PMCID： PMC1429861 DOI： 10.1111/j.1365-2125.1980.tb05832.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

16 in total

1. Five Weeks to Escape the Sleeping-pill Habit.

Authors: I Oswald; R G Priest
Journal: Br Med J Date: 1965-11-06

2. Effect of N-desmethyldiazepam (nordiazepam) and a precursor, potassium clorazepate, on sleep in man.

Authors: A N Nicholson; B M Stone; C H Clarke; H M Ferres
Journal: Br J Clin Pharmacol Date: 1976-06 Impact factor: 4.335

3. Immediate and residual effects in man of the metabolites of diazepam.

Authors: C H Clarke; A N Nicholson
Journal: Br J Clin Pharmacol Date: 1978-10 Impact factor: 4.335

4. Efficacy and residual effect evaluation of a new hypnotic, triazolam.

Authors: W Veldkamp; R N Straw; C M Metzler; H V Demissianos
Journal: J Clin Pharmacol Date: 1974 Feb-Mar Impact factor: 3.126

5. The residual effects of flurazepam.

Authors: A J Bond; M H Lader
Journal: Psychopharmacologia Date: 1973-09-28

6. Residual effects of hypnotics.

Authors: A J Bond; M H Lader
Journal: Psychopharmacologia Date: 1972

7. Activity of fosazepam, a soluble analogue of diazepam.

Authors: A N Nicholson; C M Wright
Journal: Br J Clin Pharmacol Date: 1977-08 Impact factor: 4.335

8. Intermediate use of triazolam: a sleep laboratory study.

Authors: T Roth; M Kramer; T Lutz
Journal: J Int Med Res Date: 1976 Impact factor: 1.671

9. Comparison of the residual effects of two benzodiazepines (nitrazepam and flurazepam hydrochloride) and pentobarbitone sodium on human performance.

Authors: R G Borland; A N Nicholson
Journal: Br J Clin Pharmacol Date: 1975-02 Impact factor: 4.335

10. Hypnotic activity of 3-hydroxy, N-desmethyldiazepam (oxazepam).

Authors: A N Nicholson; B M Stone
Journal: Br J Clin Pharmacol Date: 1978-05 Impact factor: 4.335

19 in total

1. Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.

Authors: G Bensimon; J Foret; D Warot; L Lacomblez; J F Thiercelin; P Simon
Journal: Br J Clin Pharmacol Date: 1990-09 Impact factor: 4.335

2. Administration of triazolam prior to recovery sleep: effects on sleep architecture, subsequent alertness and performance.

Authors: T J Balkin; V M O'Donnell; G H Kamimori; D P Redmond; G Belenky
Journal: Psychopharmacology (Berl) Date: 1989 Impact factor: 4.530

Activity of the hypnotics, flunitrazepam and triazolam, in man.

1. Five Weeks to Escape the Sleeping-pill Habit.

2. Effect of N-desmethyldiazepam (nordiazepam) and a precursor, potassium clorazepate, on sleep in man.

3. Immediate and residual effects in man of the metabolites of diazepam.

4. Efficacy and residual effect evaluation of a new hypnotic, triazolam.

5. The residual effects of flurazepam.

6. Residual effects of hypnotics.

7. Activity of fosazepam, a soluble analogue of diazepam.

8. Intermediate use of triazolam: a sleep laboratory study.

9. Comparison of the residual effects of two benzodiazepines (nitrazepam and flurazepam hydrochloride) and pentobarbitone sodium on human performance.

10. Hypnotic activity of 3-hydroxy, N-desmethyldiazepam (oxazepam).

1. Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.

2. Administration of triazolam prior to recovery sleep: effects on sleep architecture, subsequent alertness and performance.

3. Residual and acute effects of flurazepam and triazolam in normal subjects.

4. Approaches in the evaluation of hypnotics: studies with triazolam.

5. The use of short- and long-acting hypnotics in clinical medicine.

6. Residual effects of repeated doses of 0.5 and 1 mg flunitrazepam.

7. Hypnotic and residual effects of temazepam in volunteers.

8. Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold.

Review 9. Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia.

10. Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men.